Last $102.37 USD
Change Today -0.93 / -0.90%
Volume 1.1M
SIAL On Other Exchanges
As of 4:00 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

sigma-aldrich (SIAL) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/3/14 - $105.00
52 Week Low
10/9/13 - $82.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SIGMA-ALDRICH (SIAL)

sigma-aldrich (SIAL) Related Businessweek News

No Related Businessweek News Found

sigma-aldrich (SIAL) Details

Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment worldwide. Its chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. The company sells its products to commercial laboratories, pharmaceutical companies, industrial companies, universities, diagnostics companies, biotechnology companies, electronics companies, hospitals, governmental institutions, and non-profit organizations. Sigma-Aldrich Corporation was founded in 1951 and is based in St. Louis, Missouri.

9,000 Employees
Last Reported Date: 07/24/14
Founded in 1951

sigma-aldrich (SIAL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $876.9K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $465.4K
Executive Vice President and President of App...
Total Annual Compensation: $437.7K
Executive Vice President and President of SAF...
Total Annual Compensation: $386.5K
Executive Vice President and President of Res...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2013.

sigma-aldrich (SIAL) Key Developments

Sigma-Aldrich Corporation to Provide Vector Core with Sigma CRISPR Technology, Experimental Design Consultation, and Dedicated Gene Editing Bioinformaticians

Sigma-Aldrich Corporation announced that it has entered into a new gene editing partnership with the University of Michigan (U-M) Medical School's Vector Core. Under the partnership, Sigma-Aldrich will provide the Vector Core with Sigma CRISPR technology, experimental design consultation, and dedicated gene editing bioinformaticians. The partnership is poised to accelerate gene editing-based research at the U-M Medical School. The Vector Core's partnership with Sigma-Aldrich provides the entire U-M Medical School access to the experimental design, bioinformatics, and production resources that Brenner already receives from Sigma-Aldrich due to the scale of his project.

Sigma-Aldrich Corporation Unveils Cerilliant Branded Products in Canada

Sigma-Aldrich Corporation announced that its Cerilliant Snap-N-Spike | Snap-N-Shoot certified reference materials are now available through Sigma-Aldrich Canada. Service through Sigma-Aldrich Canada allows the company's Canadian customers to readily obtain Cerilliant products domestically, in local currency and language - eliminating the frustrations of customs clearance, import duties/taxes, and international shipping costs. Popular and high volume items will be stocked in the Toronto warehouse to best service Canadian customers. Products not stocked locally should be available within four business days. Cerilliant provides high quality, quantitative, Certified Reference Materials in a solution format suitable for a wide variety of critical applications including quality control testing and preparation of calibrators and controls for clinical or forensic toxicology, clinical diagnostic, urine drug analysis, and isotope dilution methods. Cerilliant's Snap-N-Spike | Snap-N-Shoot format provides laboratories consistency of concentration and eliminates tedious weighing operations and handling of difficult materials. Cerilliant provides an industry leading Certificate of Analysis including all testing data with stability, uncertainty, and traceability information to meet customer regulatory requirements. The Canadian launch marks the thirty-ninth country where Cerilliant Certified Reference Materials are available through Sigma-Aldrich including the US, all major countries in Europe, Japan, China, India, and Brazil.

Sigma-Aldrich Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014 02:05 PM

Sigma-Aldrich Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014 02:05 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Eric M. Green, Executive Vice President and President of Research.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIAL:US $102.37 USD -0.93

SIAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,223 INR +30.20
International Flavors & Fragrances Inc $100.73 USD +0.08
WR Grace & Co $96.82 USD -1.28
Waters Corp $101.58 USD -0.55
Westlake Chemical Corp $95.29 USD +0.77
View Industry Companies

Industry Analysis


Industry Average

Valuation SIAL Industry Range
Price/Earnings 24.4x
Price/Sales 4.5x
Price/Book 4.0x
Price/Cash Flow 24.1x
TEV/Sales 4.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA-ALDRICH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at